Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P 600 Small Cap ETF ( SLY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $119.51 per unit.
START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »
With SLY trading at a recent price near $106.60 per unit, that means that analysts see 12.11% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SLY's underlying holdings with notable upside to their analyst target prices are Fabrinet (
FN), Exar Corp. (
EXAR), and MiMedx Group Inc (
MDXG). Although FN has traded at a recent price of $37.96/share, the average analyst target is 32.92% higher at $50.46/share. Similarly, EXAR has 30.27% upside from the recent share price of $9.02 if the average analyst target price of $11.75/share is reached, and analysts on average are expecting MDXG to reach a target price of $11.60/share, which is 30.19% above the recent price of $8.91. Below is a twelve month price history chart comparing the stock performance of FN, EXAR, and MDXG:
Below is a summary table of the current analyst target prices discussed above:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
| SPDR S&P 600 Small Cap ETF | SLY | $106.60 | $119.51 | 12.11% |
| Fabrinet | FN | $37.96 | $50.46 | 32.92% |
| Exar Corp. | EXAR | $9.02 | $11.75 | 30.27% |
| MiMedx Group Inc | MDXG | $8.91 | $11.60 | 30.19% |
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
